|
|
CONTENTS
|
|
|
■
METASTASIS-DIRECTED
THERAPY
■
NODAL
RECURRENCE
■
PRIMARY
TUMOR TREATMENT
■
RADIOTHERAPY
■ STEREOTACTIC
RADIOTHERAPY
|
|
|
OVERVIEW
|
|
.
|
Carthon
BC.
Clinical
Considerations and Challenges in Treating Patients With
Oligometastatic Prostate Cancer.
J
Oncol Pract. 2017 Jan;13(1):19-20. doi: 10.1200/JOP.2016.018838.
Epub 2017 Jan 3.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Clement
JM, Sweeney CJ.
Evolving
Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer.
J
Oncol Pract. 2017 Jan;13(1):9-18. doi: 10.1200/JOP.2016.018523.
Epub 2017 Jan 3.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Esther J, Maughan BL, Anderson
N, Agarwal N, Hahn AW.
Management of Nonmetastatic
Castration-Resistant Prostate Cancer: Recent Advances and Future
Direction.
Curr Treat Options Oncol. 2019 Feb
11;20(2):14. doi: 10.1007/s11864-019-0611-z.
Source
| Full
text |
Similar
articles
|
|
|
.
|
James ND.
Oligometastatic Prostate Cancer Should Be
Studied and Treated Differently to High-volume Disease. Con: The
Underlying Biology is the Same, so They Should Not Be Treated
Differently.
Eur Urol Focus. 2019 Feb 22. pii:
S2405-4569(19)30021-5. doi: 10.1016/j.euf.2019.01.018. [Epub ahead
of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Khoo V.
New concepts in prostate cancer management: the
conundrum of managing oligometastatic disease in prostate
cancer-through the looking glass darkly.
Clin Radiol.
2019 Jun 5. pii: S0009-9260(19)30222-3. doi:
10.1016/j.crad.2019.05.003. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Lancia A, Zilli T, Achard V, Dirix P, Everaerts W, Gomez-Iturriaga
A, Ingrosso G, Liefhooghe N, Miralbell R, Siva S, Van der Eecken
K, Ost P.
Oligometastatic prostate cancer: The game is
afoot.
Cancer Treat Rev. 2019 Feb;73:84-90. doi:
10.1016/j.ctrv.2019.01.005. Epub 2019 Jan 17.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Rao A, Vapiwala N, Schaeffer EM, Ryan CJ.
Oligometastatic
Prostate Cancer: A Shrinking Subset or an Opportunity for Cure?
Am Soc Clin Oncol Educ Book. 2019 Jan;39:309-320. doi:
10.1200/EDBK_239041. Epub 2019 May 17.
Source
| Book
|
Similar
articles
|
|
|
.
|
Sakamoto S.
Editorial Comment to ‘Local
treatment for metastatic prostate cancer: A systematic review’.
Int J Urol. 2018 May;25(5):403-404. doi: 10.1111/iju.13588.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Slaoui A, Albisinni S, Aoun F, Assenmacher G, Al Hajj Obeid W,
Diamand R, Regragui S, Touzani A, Bakar A, Mesfioui A, Karmouni T,
Ameur A, Elkhader K, Koutani A, Ibnattya A, Roumeguere T, Peltier
A.
A systematic review of contemporary management of
oligometastatic prostate cancer: fighting a challenge or tilting
at windmills?
World J Urol. 2019 Jan 31. doi:
10.1007/s00345-019-02652-7. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Tilki D, Pompe RS, Bandini M, Marchioni M, Kretschmer A, Tian Z,
Karakiewicz PI, Evans CP.
Local treatment for metastatic
prostate cancer: A systematic review.
Int J Urol. 2018
May;25(5):390-403. doi: 10.1111/iju.13535. Epub 2018 Mar 23.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Tosoian
JJ, Gorin MA, Ross AE, Pienta KJ, Tran PT, Schaeffer EM.
Oligometastatic
prostate cancer: definitions, clinical outcomes, and treatment
considerations.
Nat
Rev Urol. 2017 Jan;14(1):15-25. doi: 10.1038/nrurol.2016.175. Epub
2016 Oct 11.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Tran
PT, Antonarakis ES.
Altering
the Natural History of Oligometastatic Prostate Cancer With Local
Therapies: Reality Versus Illusion.
J
Oncol Pract. 2017 Jan;13(1):21-24. doi: 10.1200/JOP.2016.018846.
Epub 2017 Jan 3.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Yano A, Kawakami S.
Re: Local treatment for metastatic
prostate cancer: A systematic review.
Int J Urol.
2018 Sep 30. doi: 10.1111/iju.13809. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
MEETINGS
|
|
.
|
Aluwini SS, Mehra N, Lolkema MP, Oprea-Lager DE, Yakar D,
Stoevelaar H, van der Poel H; Dutch Oligometastatic Prostate
Cancer Working Group, Busstra M, de Jong IJ, de Reijke T, de Vries
K, Heijmink S, Jenster G, Klaver S, Kneppers J, Lavalaye J, Leyten
G, Moonen L, Nagaraj J, Noordzij W, Osanto S, Oving I, Schaake E,
Scheenen T, Schoots I, Sedelaar M, Somford D, van den Berkmortel
F, van der Hulle T, van der Voort van Zyp J, van Leeuwen P, van
Moorselaar J, van Oort I, Vogel W, Westgeest H.
Oligometastatic
Prostate Cancer: Results of a Dutch Multidisciplinary Consensus
Meeting.
Eur Urol Oncol. 2019 Aug 7. pii:
S2588-9311(19)30113-0. doi: 10.1016/j.euo.2019.07.010. [Epub ahead
of print]
Source
| Full
text |
Similar
articles
|
|
|
DEFINITION
OF OLIGOMETASTATIC PROSTATE CANCER
|
|
.
|
Di Lorenzo G, Buonerba C.
Oligometastatic Prostate
Cancer: Is it Only a Matter of Perspective?
Eur Urol.
2018 Dec 24. pii: S0302-2838(18)30998-9. doi:
10.1016/j.eururo.2018.12.010. [Epub ahead of print]
Opinion
Source
| Full
text |
Similar
articles
|
|
|
.
|
Foster CC, Weichselbaum RR, Pitroda SP. Foster CC, Weichselbaum
RR, Pitroda SP.
Oligometastatic prostate cancer: Reality
or figment of imagination?
Cancer.
2019 Feb 1;125(3):340-352. doi: 10.1002/cncr.31860. Epub 2018
Dec 6.
Source
| Full
text |
Similar
articles
|
|
|
DIFFERENTIATION
OF OLIGO- AND POLYMETASTATIC PROSTATE CANCER
|
|
.
|
Dhondt B, De Bleser E, Claeys T, Buelens S, Lumen N, Vandesompele
J, Beckers A, Fonteyne V, Van der Eecken K, De Bruycker A, Paul J,
Gramme P, Ost P.
Discovery and validation of a serum
microRNA signature to characterize oligo- and polymetastatic
prostate cancer: not ready for prime time.
World J Urol.
2018 Dec 21. doi: 10.1007/s00345-018-2609-8. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
HORMONE-SENSITIVE
PCA
|
|
.
|
Chow K, McCoy P, Stuchbery R, Corcoran NM, Hovens CM.
Developments in oligometastatic hormone-sensitive
prostate cancer.
World J Urol. 2018 Oct 31. doi:
10.1007/s00345-018-2542-x. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Kothari G, Ost P, Cheung P, Blanchard P, Tree AC, van As NJ, Lo
SS, Moghanaki D, Loblaw A, Siva S.
Trends in Management
of Oligometastatic Hormone-Sensitive Prostate Cancer.
Curr
Oncol Rep. 2019 Mar 27;21(5):43. doi: 10.1007/s11912-019-0791-5.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Koo KC, Dasgupta P.
Treatment of Oligometastatic
Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
Yonsei
Med J. 2018 Jul;59(5):567-579. doi: 10.3349/ymj.2018.59.5.567.
Source
| Full
text |
Similar
articles
|
|
|
BONE
DISEASE
|
|
.
|
Habl
G, Straube C, Schiller K, Duma MN, Oechsner M, Kessel KA, Eiber M,
Schwaiger M, Kübler H, Gschwend JE, Combs SE.
Oligometastases
from prostate cancer: local treatment with stereotactic body
radiotherapy (SBRT).
BMC
Cancer. 2017 May 22;17(1):361. doi: 10.1186/s12885-017-3341-2.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Sridharan
S, Steigler A, Spry NA, Joseph D, Lamb DS, Matthews JH, Atkinson
C, Tai KH, Duchesne G, Christie D, Attia J, Holliday EG, Denham
JW.
Oligometastatic
bone disease in prostate cancer patients treated on the TROG 03.04
RADAR trial.
Radiother
Oncol. 2016 Aug 12. pii: S0167-8140(16)31237-3. doi:
10.1016/j.radonc.2016.07.021. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
HEPATIC
METASTASIS
|
|
.
|
Wang
SC, McCarthy LP, Mehdi S.
Isolated
Hepatic Metastasis from Prostate Carcinoma.
Urol
Case Rep. 2016 Dec 6;10:51-53.
Source
|
Full
text |
Similar
articles
|
|
|
NEWLY
DIAGNOSED OLIGOMETASTATIC PROSTATE CANCER
|
|
.
|
Tsumura H, Ishiyama H, Tabata KI, Sekiguchi A, Kawakami S, Satoh
T, Kitano M, Iwamura M.
Long-term outcomes of combining
prostate brachytherapy and metastasis-directed radiotherapy in
newly diagnosed oligometastatic prostate cancer: A retrospective
cohort study.
Prostate. 2018 Dec 26. doi:
10.1002/pros.23757. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
RADICAL
PROSTATECTOMY
|
|
.
|
Ahmad AE, Leão R, Hamilton RJ.
Radical
Prostatectomy for Patients With Oligometastatic Prostate Cancer.
Oncology (Williston Park). 2017 Nov 15;31(11):794-802.
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
|